Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control (Q38490183)

3 September 2017

title

Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control (English)

1 reference

3 September 2017

M-H Son

1

1 reference

3 September 2017

H D Kim

2

1 reference

3 September 2017

Y N Chae

3

1 reference

3 September 2017

M-K Kim

4

1 reference

3 September 2017

C Y Shin

5

1 reference

3 September 2017

G J Ahn

6

1 reference

3 September 2017

S-H Choi

7

1 reference

3 September 2017

E K Yang

8

1 reference

3 September 2017

K-J Park

9

1 reference

3 September 2017

H W Chae

10

1 reference

3 September 2017

H-S Moon

11

1 reference

3 September 2017

S-H Kim

12

1 reference

3 September 2017

Y-G Shin

13

1 reference

3 September 2017

S-H Yoon

14

1 reference

3 September 2017

language of work or name

English

0 references

publication date

22 December 2009

1 reference

International Journal of Obesity

3 September 2017

published in

1 reference

3 September 2017

volume

34

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

547-556

1 reference

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

The gastrointestinal pharmacology of cannabinoids: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

End of the line for cannabinoid receptor 1 as an anti-obesity target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

The unfolding cannabinoid story on energy homeostasis: central or peripheral site of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Application of a sample pooling method for the accelerated assessment of the rate of uptake of drugs by the brain in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

CB1 cannabinoid receptor-mediated modulation of food intake in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Dietary conjugated linoleic acid reduces body fat mass and affects gene expression of proteins regulating energy metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

7 January 2021

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

7 January 2021

A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

7 January 2021

Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

7 January 2021

A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

7 January 2021

The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.253

7 January 2021

Identifiers

DOI

10.1038/IJO.2009.253

1 reference

Dimensions Publication ID

3 September 2017

1042010231

0 references

1 reference